Cyberonics’ VNS Therapy Approvable As Last-Resort Depression Fix – Panel

FDA's Neurological Devices Panel set aside its desire for an additional, randomized trial of Cyberonics' VNS Therapy depression indication at a June 15 meeting to review the device in Gaithersburg, Md